MEDIFAST INC (MED)
Official siteCONSUMER CYCLICAL • PERSONAL SERVICES • NYSE
Market Cap: $145.04M
Last updated: Nov 17, 2026 at 11:06 AM ET
MEDIFAST INC (MED) Financials: Revenue, Profit and Cash Flow
MEDIFAST INC reported revenue of $385.79M for the fiscal year ended Dec 31, 2025, down 36.0% from the year before. That year, net income was -$18.67M with a net margin of -4.8%, operating cash flow was $6.86M and free cash flow was $1.25M. The quarter ended Sep 30, 2026 had revenue of $72.05M and net income of -$17.51M.
Revenue and Margins
The operating margin was -3.7% in the fiscal year ended Dec 2025, the lowest of the 10 years shown. Over the 9 years to Dec 2025, revenue grew from $274.53M, a compound annual rate of 3.9%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $385.79M | -36.0% | 71.3% | -3.7% | -4.8% |
| Dec 2024 | $602.46M | -43.8% | 73.8% | 0.5% | 0.3% |
| Dec 2023 | $1.07B | -32.9% | 72.4% | 11.8% | 9.3% |
| Dec 2022 | $1.60B | +4.8% | 71.3% | 11.6% | 9.0% |
| Dec 2021 | $1.53B | +63.2% | 73.9% | 14.2% | 10.7% |
| Dec 2020 | $934.84M | +31.0% | 74.6% | 14.4% | 11.0% |
| Dec 2019 | $713.67M | +42.4% | 75.2% | 12.8% | 10.9% |
| Dec 2018 | $501.00M | +66.1% | 75.8% | 13.8% | 11.1% |
| Dec 2017 | $301.56M | +9.8% | 75.5% | 13.1% | 9.2% |
| Dec 2016 | $274.53M | N/A | 74.9% | 9.8% | 6.5% |
Income Statement
In the fiscal year ended Dec 2025, the company posted a net loss after a profit the year before. In the quarter ended Sep 2026, the net loss widened from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $385.79M | $602.46M | $1.07B | $1.60B | $1.53B | $934.84M | $713.67M | $501.00M | $301.56M | $274.53M |
| Cost of revenue | $110.60M | $157.84M | $296.20M | $458.16M | $398.49M | $237.03M | $176.81M | $121.10M | $73.75M | $68.87M |
| Gross profit | $275.19M | $444.62M | $775.85M | $1.14B | $1.13B | $697.82M | $536.86M | $379.90M | $227.81M | $205.66M |
| Operating income | -$14.21M | $2.88M | $126.40M | $184.81M | $216.24M | $134.16M | $91.04M | $69.06M | $39.63M | $26.86M |
| Net income | -$18.67M | $2.09M | $99.42M | $143.57M | $164.03M | $102.86M | $77.92M | $55.79M | $27.72M | $17.84M |
| EBITDA | $2.42M | $10.89M | $139.25M | $195.75M | $223.26M | $138.66M | $96.15M | $74.25M | $44.68M | $32.67M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $72.05M | $76.38M | $76.04M | $75.10M | $89.41M | $105.56M | $115.73M | $119.00M | $140.16M | $168.56M | $174.74M | $191.01M |
| Gross profit | $50.04M | $53.40M | $51.76M | $52.14M | $62.16M | $76.64M | $84.25M | $88.22M | $105.67M | $123.44M | $127.29M | $141.37M |
| Operating income | -$19.36M | -$4.33M | -$3.29M | -$7.80M | -$4.08M | -$1.07M | -$1.26M | $708.00K | $2.11M | -$7.88M | $7.94M | $8.68M |
| Net income | -$17.51M | -$3.10M | -$2.12M | -$18.12M | -$2.26M | $2.48M | -$772.00K | $800.00K | $1.13M | -$8.15M | $8.32M | $6.04M |
Balance Sheet
As of Dec 2025, cash and equivalents exceeded short-term debt of $4.60M by $84.70M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $247.97M | $284.21M | $309.91M | $316.21M | $398.33M | $276.08M | $194.65M | $169.43M | $145.93M | $121.22M |
| Current assets | $201.68M | $214.40M | $224.03M | $222.78M | $306.87M | $234.31M | $154.15M | $145.52M | $125.20M | $101.30M |
| Cash and equivalents | $89.30M | $90.93M | $94.44M | $87.69M | $104.18M | $163.72M | $76.97M | $81.36M | $75.08M | $52.44M |
| Total liabilities | $49.05M | $74.10M | $108.43M | $161.17M | $195.85M | $118.84M | $89.82M | $60.32M | $37.35M | $25.20M |
| Short-term debt | $4.60M | $6.18M | $5.88M | $5.78M | $6.52M | $3.67M | $3.17M | $0 | $0 | $0 |
| Long-term debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $0 | $779.00K |
| Shareholder equity | $198.92M | $210.11M | $201.48M | $155.04M | $202.47M | $157.25M | $104.83M | $109.11M | $108.58M | $96.02M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $239.76M | $260.40M | $252.05M | $257.01M | $268.21M | $269.33M | $280.01M | $284.21M | $291.24M | $293.53M | $302.76M | $309.91M |
| Total liabilities | $59.49M | $64.02M | $54.37M | $58.09M | $53.50M | $53.33M | $69.05M | $74.10M | $83.89M | $88.25M | $91.80M | $108.43M |
| Cash and equivalents | $58.37M | $71.91M | $71.53M | $89.30M | $99.53M | $101.69M | $91.72M | $90.93M | $115.31M | $108.02M | $97.47M | $94.44M |
| Shareholder equity | $180.28M | $196.38M | $197.68M | $198.92M | $214.71M | $216.00M | $210.96M | $210.11M | $207.34M | $205.28M | $210.96M | $201.48M |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 18.2% of operating cash flow. Dividends and share repurchases together came to 45.1% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $6.86M | $24.48M | $147.66M | $194.57M | $94.55M | $145.20M | $84.26M | $60.82M | $43.24M | $25.35M |
| Capital expenditures | $5.61M | $7.45M | $6.48M | $16.68M | $34.21M | $5.89M | $10.06M | $4.94M | $3.24M | $2.88M |
| Free cash flow | $1.25M | $17.02M | $141.17M | $177.89M | $60.34M | $139.31M | $74.20M | $55.88M | $39.99M | $22.47M |
| Dividends paid | $195.00K | $715.00K | $73.02M | $71.62M | $63.86M | $53.19M | $35.40M | $23.16M | $15.39M | $11.89M |
| Share repurchases | $369.00K | $836.00K | $6.96M | $127.96M | $62.09M | $5.55M | $47.21M | $30.71M | $2.54M | $1.34M |
| Investing cash flow | -$7.93M | -$26.52M | -$61.05M | -$11.41M | -$29.06M | -$1.28M | -$6.33M | -$1.20M | -$3.16M | -$2.04M |
| Financing cash flow | -$564.00K | -$1.51M | -$79.79M | -$199.58M | -$125.13M | -$57.14M | -$82.32M | -$53.33M | -$17.36M | -$12.92M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $3.29M | $1.70M | $260.00K | -$5.28M | $12.11M | -$3.38M | $3.41M | -$4.95M | $9.07M | $13.07M | $7.28M | $10.52M |
| Capital expenditures | $427.00K | $969.00K | $1.10M | $1.35M | $1.36M | $1.38M | $1.52M | $2.29M | $1.39M | $1.94M | $1.84M | $946.00K |
| Free cash flow | $2.87M | $728.00K | -$836.00K | -$6.63M | $10.75M | -$4.76M | $1.88M | -$7.23M | $7.68M | $11.13M | $5.44M | $9.58M |
Frequently Asked Questions About MED
What is MEDIFAST INC's annual revenue?
MEDIFAST INC reported revenue of $385.79M for the fiscal year ended Dec 31, 2025.
How fast is MEDIFAST INC's revenue growing?
Revenue was down 36.0% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -37.7%.
Is MEDIFAST INC profitable?
No. MEDIFAST INC reported net income of -$18.67M for the fiscal year ended Dec 31, 2025, with a net margin of -4.8%.
How much free cash flow does MED generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $6.86M minus capital expenditures of $5.61M produced free cash flow of $1.25M.
How much debt does MEDIFAST INC have?
The balance sheet dated Dec 31, 2025 reported short-term debt of $4.60M and cash and equivalents of $89.30M.
MED pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors